Centrus Energy: Assessing the Valuation Premium After Major Government Contract

A substantial new government order has cemented Centrus Energy Corp.’s pivotal role in America’s advanced nuclear fuel supply chain. However, a closer examination of the company’s financial metrics reveals a significant valuation gap, prompting investors to question whether the current stock price fully aligns with fundamentals.

Strategic Contract and Economic Impact

On January 6, 2026, the U.S. Department of Energy (DOE) awarded Centrus Energy a task order valued at $900 million. This funding is designated for the expansion of the company’s enrichment facility in Piketon, Ohio, to enable the commercial production of High-Assay Low-Enriched Uranium (HALEU). This award was part of a broader $2.7 billion initiative, underscoring a clear federal policy priority to bolster domestic uranium enrichment capabilities and ensure supply security.

The company estimates the expansion project will generate approximately 1,000 construction jobs and create around 300 new permanent operational positions in Ohio. Additionally, hundreds more roles are expected to be supported at supplier networks and at the Oak Ridge site, where centrifuges are manufactured. This move strategically embeds Centrus within the national framework for advanced reactor development and reduces reliance on foreign fuel suppliers.

Should investors sell immediately? Or is it worth buying Centrus Energy?

Valuation Metrics and Market Signals

While the government backing enhances the firm’s strategic profile, key valuation indicators appear stretched. A summary of the relevant data follows:
– Current Share Price: $307.57
– DCF Intrinsic Value Estimate: $258.64 — suggesting the equity may be overvalued by approximately 18.9%
– P/E Ratio: 49.27x (compared to an Oil & Gas industry average of 13.70x and a peer average of 16.80x)
– Institutional Activity: Investment firm D. E. Shaw reported a 5.6% stake in Centrus as of January 14, 2026, with a reporting date of January 7, 2026.

The elevated multiples reflect substantial market expectations for future growth. The realization of this growth, however, is contingent upon several factors: the economic scalability of HALEU production, the timely execution of the capacity expansion, and the eventual profitability of the new operations.

Investment Outlook: Conditions for a Sustained Rerating

There is no doubt the DOE contract fortifies Centrus Energy’s standing in the U.S. nuclear fuel sector. Nevertheless, a durable rerating of the stock seems tied to concrete operational milestones. These include demonstrable revenue and margin accretion directly from HALEU sales, the on-schedule commissioning of expanded capacity, or subsequent revisions to analyst discounted cash flow models. In the absence of such tangible evidence, the shares may remain vulnerable to valuation corrections despite the powerful tailwind of government support.